Genetic Optimization: The Debate Over Designing Unborn Children
Major advances in science have brought to life a once-impossible and much-debated question: Would you design your unborn child? The concept of “genetic optimization” has sparked a heated discussion about the ethics of reproductive genetics.
Introduction to Genetic Optimization
Kian Sadeghi, the founder and CEO of Nucleus Genomics, believes that every parent has the right to choose the characteristics they want for their child, from height to weight to intelligence. His company has already helped thousands of families, backed by investors and prominent tech entrepreneurs.
Parental Rights and Genetic Testing
Sadeghi argues that genetic testing companies like Nucleus are giving parents the information they need to know about their future child. The company’s program, IVF+, includes full DNA scans of both parents and up to 20 embryos created through in vitro fertilization, resulting in a user-friendly menu that allows parents to compare and select traits.
Advanced DNA Screenings
The company tests embryo samples for over 2,000 traits and conditions, including eye color, hair color, intelligence, and even acne. It can also estimate genetic predisposition to conditions such as depression, autism, and bipolar disorder. This “genetic optimization” allows parents to minimize disease while maximizing the traits they prefer.
Ethical Concerns and Criticisms
Critics have drawn comparisons to the term “eugenics,” sparking an ethical debate about reproductive genetics. Some medical experts point out the ethical dilemmas posed by these new reproductive technologies, arguing that the race for the “perfect baby” is creating an “ethical mess.” The American College of Medical Genetics and Genomics has stated that the practice of genetic screening and the use of polygenic risk scores for embryo selection has “moved too quickly and had too little evidence.”
Responding to Criticisms
Sadeghi remains confident in the data, saying that his company’s predictors can predict longevity from an embryo’s DNA better than any other genetic model ever created. He rejects criticism that he is creating a new class of “superhumans,” arguing that DNA is not fate and that other factors such as education and chance will always play a role in a child’s life.
Conclusion
The debate over genetic optimization and reproductive genetics is complex and multifaceted. While some argue that it is a parent’s right to choose the characteristics of their child, others raise concerns about the ethics and potential consequences of such technologies. As companies like Nucleus continue to grow, it is essential to consider the implications of these advancements and ensure that they are used responsibly and with careful consideration of the potential risks and benefits.
